EVOMMUNE INC (EVMN) Stock Income Statement
NYSE:EVMN • US30054Y1073
Current stock price
27.45 USD
+0.68 (+2.54%)
At close:
26.92 USD
-0.53 (-1.93%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | ||||
|---|---|---|---|---|---|---|
| Revenue | 13.00M | 7.00M | 5.00M | |||
| Operating Expenses | 94.07M | 77.01M | 42.85M | |||
| Research and Development | 74.04M | 64.24M | 32.00M | |||
| Selling, General, and Administrative Expenses | 20.03M | 12.77M | 10.85M | |||
| Operating Income | -81.07M | -70.01M | -37.85M | |||
| Interest Income/Expense | 3.32M | 3.24M | 3.86M | |||
| Other Income/Expense | 8.88M | -37.00K | -59.00K | |||
| Income Before Taxes | -68.87M | -66.81M | -34.05M | |||
| Net Income | -68.87M | -68.31M | -34.05M | |||
| EBITDA | -79.68M | -68.73M | -36.85M | |||
| Per Share Data | ||||||
| EPS Diluted Total Ops | -2.29 | -2.27 | -1.13 | |||
| Statistics | ||||||
| Profit Margin | -529.77% | -975.83% | -681.06% | |||
| Operating Profit Margin | -623.62% | -1000.19% | -757.00% | |||
All data in USD